The review delineates ‘borderline resectable colorectal liver metastases’ (BR-CRLM) as a distinct category, integrating both surgical and oncological criteria for optimal decision-making. Current treatments highlight the necessity of pre-operative chemotherapy and advanced surgical interventions, which now offer substantial long-term survival benefits. By emphasizing this classification, clinicians can better tailor therapeutic strategies, involving locoregional therapies and targeted approaches, enhancing outcomes for patients who previously faced limited options.
Review by Varty GP, Patkar S (…) Goel M et 2 al. in J Gastrointest Surg
Copyright © 2024. Published by Elsevier Inc.